Page last updated: 2024-09-05

sorafenib and cholecalciferol

sorafenib has been researched along with cholecalciferol in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (cholecalciferol)	Trials (cholecalciferol)	Recent Studies (post-2010) (cholecalciferol)
6,520	730	5,251	8,234	1,425	3,471

Protein Interaction Comparison

Protein	Taxonomy	sorafenib (IC50)	cholecalciferol (IC50)
Vitamin D3 receptor	Homo sapiens (human)		0.087

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abuo-Rahma, GEA; Badr, M; Bass, AKA; El-Zoghbi, MS; Mohamed, MFA; Nageeb, EM	1

Reviews

1 review(s) available for sorafenib and cholecalciferol

Article	Year
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors	2021

Article

Year

Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.

European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors

2021